Beacon Pointe Advisors, LLC

Position in HLN — Haleon plc

CIK 1744317 NEWPORT BEACH, CA

Position in HLN

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$485,474

+$225,284 QoQ

Shares Held

48,499

+88.4% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

14 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Beacon Pointe Advisors, LLC holds $6,694,336 across 7 Drug Manufacturers - Specialty & Generic names. HLN ranks #4 (7.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	29,753	$3,517,102
2	UTHR	UNITED THERAPEUTICS Corp	2,417	$1,433,232
3	TAK	Takeda Pharmaceutical Co Ltd	32,930	$609,863
4	HLN	Haleon plc This page	48,499	$485,474
5	VTRS	Viatris Inc	27,557	$372,295
6	AQST	Aquestive Therapeutics, Inc.	60,500	$251,075
7	BTAI	BioXcel Therapeutics, Inc.	18,877	$25,295

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$485,474	48,499	+88.4%	Shares	Sole	2026-05-15
2025-12-31	$260,190	25,736	+39.9%	Shares	Sole	2026-02-18
2025-09-30	$164,994	18,394	+37.3%	Shares	Sole	2025-11-14
2025-06-30	$138,885	13,393	-48.9%	Shares	Sole	2025-08-13
2025-03-31	$269,505	26,191	+72.8%	Shares	Sole	2025-05-13
2024-12-31	$144,578	15,155	+2.6%	Shares	Sole	2025-02-14
2024-09-30	$156,256	14,769	-18.4%	Shares	Sole	2024-11-14
2024-06-30	$149,497	18,099	+14.4%	Shares	Sole	2024-08-12
2024-03-31	$134,328	15,822	+8.4%	Shares	Sole	2024-05-14
2023-12-31	$120,158	14,600	+4.5%	Shares	Sole	2024-02-08
2023-09-30	$116,378	13,971	+3.0%	Shares	Sole	2023-11-14
2023-06-30	$113,641	13,561	-18.7%	Shares	Sole	2023-08-14
2023-03-31	$135,750	16,677	+25.3%	Shares	Sole	2023-05-12
2022-12-31	$106,480	13,310	—	Shares	Sole	2023-02-14
No filing history on record for this holder in this stock.